SUBSCRIPTION AGREEMENT
Exhibit 99.2
Filing Version
THIS AGREEMENT is made as of the 27 day of April, 2017.
BETWEEN:
Fuzhou Bonded Zone Hejili Equity Investment Limited Partnership, a limited partnership existing under the laws of the People’s Republic of China, with Chinese unified social credit code as 91350105MA3494DT6K (the “Investor”)
- and -
HYDROGENICS CORPORATION, a corporation existing under the laws of Canada (the “Company”)
WHEREAS the Investor has agreed to purchase the Purchased Securities (as defined herein) from the Company, and the Company has agreed to issue and sell the Purchased Securities to the Investor, on the terms and conditions set out in this Agreement.
NOW THEREFORE, in consideration of the premises and the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
Article 1
DEFINITIONS AND INTERPRETATION
| 1.1 | Defined Terms |
For the purposes of this Agreement (including the recitals hereto), unless the context otherwise requires, the following terms shall have the respective meanings given to them, as set out below, and grammatical variations of such terms shall have corresponding meanings:
“Acting Jointly or In Concert” means a Person acting jointly or in concert with another Person or Persons within the meaning of National Instrument 62-104 – Take-Over Bids and Issuer Bids.
“Activist Investor” means, as of any date, (a) any Person that has, directly or indirectly through its publicly-disclosed Affiliates, whether individually or as a member of a publicly-disclosed group or Acting Jointly or In Concert with any other Person, within the two-year period immediately preceding such date, and in each case with respect to the Company, any of its Subsidiaries or any of its or their equity securities (i) publicly made, engaged in or been a participant in any “solicitation” of “proxies” (as such terms are defined or used in the U.S. Exchange Act and the Canada Business Corporations Act) to vote any equity securities of the Company or any of its Subsidiaries, including in connection with a proposed change in control or other extraordinary or fundamental transaction involving the Company or any of its Subsidiaries, or a public proposal for the election or replacement of any directors of the Company or any of its Subsidiaries, that has not been approved by the board of directors of the Company or such Subsidiary, (ii) called, or sought to call, a meeting of shareholders of the Company or any of its Subsidiaries or initiated or submitted any shareholder proposal for action by shareholders of the Company or any of its Subsidiaries (including through action by written consent), in each case that has not been approved and publicly recommended by the board of directors of the Company or such Subsidiary, (iii) otherwise publicly, alone or Acting Jointly or In Concert with others, to seek to control or influence the board of directors, management or shareholders of the Company or any of its Subsidiaries (provided that this clause (iii) is not intended to apply to the activities of any member of the board of directors of the Company or such Subsidiary, with respect to the Company or such Subsidiary, taken in good faith solely in his or her capacity as a director of the Company or such Subsidiary), (iv) publicly disclosed any intention, plan, arrangement or other agreement to do any of the foregoing, or (b) any Person identified on the most-recently available SharkWatch 50 list as of such date, or (c) any Affiliate of any Person contemplated in (a) and (b) above.
| -2- |
“Affiliate” means, with respect to any Person, any other Person which directly or indirectly, controls, or is controlled by, or is under common control with, such Person.
“Applicable Law” means any law (including common law and equity), any international or other treaty, any domestic or foreign constitution or any multinational, federal, provincial, territorial, state, municipal, county or local statute, law, ordinance, code, rule, regulation, Order (including any Securities Laws and any consent decree or administrative Order), or Authorization of a Governmental Body in any case applicable to any specified Person, property, transaction or event, or any such Person’s property or assets.
“Approval Deadline” the meaning set out in Section 4.3(d).
“Approved Change of Control Transaction” means a take-over bid, tender offer or exchange offer by any Person, or a merger, amalgamation, arrangement, reorganization or other business combination or similar transaction involving the Company, where such take-over bid, tender offer, exchange offer, merger, amalgamation, arrangement, reorganization or other business combination or similar transaction has been approved and publicly recommended for acceptance by shareholders of the Company by the Board.
“Associate”, in respect of a relationship with a Person, means
| (a) | a body corporate of which that Person beneficially owns or controls, directly or indirectly, shares or securities currently convertible into shares carrying more than 10% of the voting rights under all circumstances or by reason of the occurrence of an event that has occurred and is continuing, or a currently exercisable option or right to purchase such shares or such convertible securities; |
| -3- |
| (b) | a partner of that Person acting on behalf of the partnership of which they are partners; |
| (c) | a trust or estate or succession in which that Person has a substantial beneficial interest or in respect of which that Person serves as a trustee or liquidator of the succession or in a similar capacity; |
| (d) | a spouse of that Person or an individual who is cohabiting with that person in a conjugal relationship, having so cohabited for a period of at least one year; or |
| (e) | a Related Person of that Person. |
“Authorization” means any authorization, approval, consent, concession, exemption, license, lease, grant, permit, franchise, right, privilege or no-action letter from any Governmental Body having jurisdiction with respect to any specified Person, property, transaction or event, or with respect to any of such Person’s property or business and affairs or from any Person in connection with any easements, contractual rights or other matters.
“Board” means the Board of directors of the Company.
“Business Day” means any day other than a Saturday, Sunday or a day on which banking institutions in Toronto, Ontario or Beijing, China are authorized or obligated by law to close.
“Chinese Approvals” has the meaning set out in Section 5.3(h).
“Closing” means the closing of the purchase and sale of the Purchased Securities.
“Closing Date” means the second Business Day after the satisfaction or waiver of the conditions set forth in Sections 5.2 and 5.3 (other than the delivery of items to be delivered on the Closing Date and the satisfaction of those conditions that, by their terms, cannot be satisfied until the Closing Date) or such other date mutually agreed to by the Investor and the Company.
“Closing Time” means 10:00 a.m. (Toronto time) on the Closing Date or such other time mutually agreed to by the Investor and the Company.
“Common Shares” means the common shares which the Company is authorized to issue.
“Competitor” means any Person set forth on Schedule “A”.
“CSA” means the securities commissions and other securities regulatory authorities in each of the provinces and territories of Canada.
“EDC Warrants” has the meaning set out in Section 3.1(e).
| -4- |
“Encumbrance” means any mortgage, debenture, pledge, hypothec, lien, charge, assignment by way of security, consignment, lease, hypothecation, security interest, including a purchase money security interest, or other security agreement, trust or arrangement having the effect of security for the payment of any debt, liability or obligation, title retention right, or any other encumbrance or prior claim of any nature or kind whatsoever.
“Exchange Approvals” has the meaning set out in Section 5.1(c)(v).
“Excluded Issuance” means the issuance by the Company of (a) securities to the Company’s directors, officers, employees or consultants upon the exercise of options or other issuances under applicable equity incentive plans of the Company; (b) securities upon the conversion of securities convertible or exercisable into equity securities that are currently outstanding as of the date of this Agreement (including, for greater certainty, the Lender Warrants and the EDC Warrants); (c) securities issuable as a stock dividend; (d) securities issued in connection with an acquisition, merger, business combination, tender offer, take-over bid, arrangement, asset purchase transaction, joint venture or similar transaction; or (e) securities pursuant to a rights offering by the Company.
“GM” means General Motors Holdings, LLC.
“GM Agreement” means the Governance Agreement between the Company and GM dated October 16, 2001.
“Governmental Body” means any domestic or foreign federal, provincial, regional, state, municipal or other government, governmental department, agency, authority or body (whether administrative, legislative, executive or otherwise), court, tribunal, commission or commissioner, bureau, minister or ministry, board or agency, or other regulatory authority, including any securities regulatory authorities or stock exchange.
“ICC” has the meaning set out in Section 7.5.
“Intellectual Property” means any and all intellectual property (whether foreign or domestic, registered or unregistered) owned by the Company or its Subsidiaries or used in the operation, conduct or maintenance of the business, as it is currently operated, conducted or maintained, including: (i) all inventions (whether patentable or unpatentable and whether or not reduced to practice) and all patents, patent applications and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions and re-examinations thereof; (ii) all trademarks, trade-names, trade dress, logos, business names, corporate names, domain names, uniform resource locators (URL’s) and the internet websites related thereto, and including all goodwill associated therewith and all applications, registrations and renewals in connection therewith; (iii) all copyrightable works of authorship, all copyrights and all applications, registrations and renewals in connection therewith; (iv) all designs, industrial designs, design patents and all applications, registrations and renewals in connection therewith; (v) all proprietary, technical or confidential information, including all trade secrets, processes, procedures, know-how, show-how, formulae, methods, data, compilations, databases and the information contained therein, together with all business and financial information relating to the Company and its Subsidiaries; and (vi) all computer software (including all source code, object code and related documentation).
| -5- |
“Investor Group Parties” means the Investor and any of its officers, directors of its general partner, agents and/or any of their respective Affiliates and/or Associates and/or any Person Acting Jointly or In Concert with the Investor and/or any of its Affiliates and/or Associates and an “Investor Group Party” shall mean any of such Persons.
“Investor Nominee” has the meaning set out in Section 4.4(a).
“Investor Nominee Notice” has the meaning set out in Section 4.4(a).
“Investor Nominee Notice Date” has the meaning set out in Section 4.4(a)(iv)(A).
[REDACTED – COMMERCIALLY SENSITIVE INFORMATION]
“Legal Qualification Requirement” has the meaning set out in Section 4.4(a).
“Lender Warrants” has the meaning set out in Section 3.1(e).
“NASDAQ” means the Nasdaq Global Market or any successor thereto.
“NewCo” has the meaning set out in Section 4.7.
“NI 45-106” means National Instrument 45-106 – Prospectus Exemptions.
“Nominee Right Threshold” has the meaning set out in Section 4.4(a).
“Offered Securities” has the meaning set out in Section 4.3(a).
“Offering” has the meaning set out in Section 4.3(a).
“Order” means any order, directive, decree, judgment, ruling, award, injunction, direction or request of any Governmental Body or other decision-making authority of competent jurisdiction.
“Outside Date” means June 12, 2017, provided that the Company may extend the Outside Date for an additional 30 days (in 15 day increments) if the Chinese Approvals or the Exchange Approvals have not been obtained by the original Outside Date (or any extension thereof) by giving written notice to the Investor to such effect no later than two Business Days prior to the original Outside Date (or any extension thereof).
“Outstanding Common Shares” means at a given time the total number of issued and outstanding Common Shares, excluding, for greater certainty, for the purposes of determining the total number of Common Shares issued and outstanding, any and all Common Shares issuable pursuant to the any outstanding stock options, warrants or other rights.
| -6- |
“PCMLA” means the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), as amended.
“Permitted Bid” means any tender offer or take-over bid for the Common Shares that is made by takeover bid circular or similar document in compliance with Securities Laws that is not made by the Investor or any Investor Group Party.
“Permitted Lender” means a bona fide arm’s length third party lender that is a financial institution in the business of lending money.
“Permitted Pledge” means a pledge or hypothecation of Purchased Securities by the Investor to a Permitted Lender and in respect of which (i) Purchased Securities representing no more than 5% of the Outstanding Common Shares are pledged to or hypothecated without the written consent of the Company, or (ii) if Purchased Securities representing more than 5% of the Outstanding Common Shares need to pledged to or hypothecated, with the Company’s written consent, which may be granted or withheld in its sole discretion, in favour of: (A) any one Permitted Lender, or (B) two or more Permitted Lenders that are Affiliates, Associates or Acting Jointly or in Concert with one another, provided that in no event shall the Investor pledge or hypothecate Purchased Securities representing more than 9.9% of the Outstanding Common Shares.
“Permitted Transfer” means (a) a Transfer of Common Shares pursuant to an Approved Change of Control Transaction or a tender of Common Shares made in response to, and no earlier than three (3) days prior to the expiry of, a Permitted Bid so long as such Transfer is in accordance with Applicable Law (which, for greater certainty, shall not permit the entering into of any lock-up, support or voting agreement pursuant to a Permitted Bid unless the Permitted Bid is an Approved Change of Control Transaction) or (b) a sale of Common Shares after the Restricted Period on or through the facilities of the TSX or NASDAQ in an orderly fashion and in a manner that does not disrupt the market (and, for greater certainty, not by way of a pre-arranged sale or a private agreement) and provided further that the Transfer is not specifically directed to be made to a particular counterparty and the Investor does not believe, after reasonable inquiry, that the Transfer is or will be to any Competitor or Activist Investor.
“Person” means and includes individuals, corporations, bodies corporate, limited or general partnerships, joint stock companies, limited liability companies, joint ventures, associations, companies, trusts, banks, trust companies, Governmental Bodies or any other type of organization or entity, whether or not a legal entity.
“Personal Information” has the meaning set out in Section 4.9(n).
“Pre-Emptive Right” has the meaning set out in Section 4.3(a).
“Pre-Emptive Right Closing Date” has the meaning set out in Section 4.3(d).
“Pre-Emptive Right Offer Notice” has the meaning set out in Section 4.3(b).
“Pre-Emptive Right Offer Period” has the meaning set out in Section 4.3(c).
| -7- |
“Pre-Emptive Right Ownership Threshold” has the meaning set out in Section 4.3(f).
“Public Disclosure Documents” means, collectively, all reports, schedules, forms, statements and any other disclosure documents (including exhibits and other information incorporated therein) filed by the Company with the Securities Regulators since January 1, 2016 and on or before the date of this Agreement, together with any documents filed or furnished during such period by the Company to the SEC on Current Reports on Form 6-K, in each case, that are available to the public on XXXXX or SEDAR.
“Purchase Price” means $7.827811992 per Purchased Security.
“Purchased Securities” means 2,682,742 Common Shares.
“Qualification Requirements” has the meaning set out in Section 4.4(a).
“Related Person”, in respect of a relationship with a Person that is an individual, means any parent, son, daughter or sibling of such Person.
“Restricted Period” means the period commencing on the Closing Date and ending on the date that is the one (1) year anniversary of the Closing Date.
“Rules” has the meaning set out in Section 7.5.
“SEC” means the United States Securities and Exchange Commission.
“Securities Laws” means all applicable securities laws and the respective regulations made thereunder, together with applicable published fee schedules, prescribed forms, policy statements, notices, orders, blanket rulings and other regulatory instruments of the Securities Regulators, and all rules, policies and requirements of the NASDAQ, the TSX, and any other stock exchange on which securities of the Company are traded and including U.S. Securities Laws.
“Securities Regulators” means, collectively, the CSA and the SEC.
“SEDAR” means the System for Electronic Document Analysis and Retrieval of the Canadian Securities Administrators.
“Subscription Proceeds” means US$21,000,000.
“Subsidiary” means with respect to any Person, any other Person which is controlled directly or indirectly by that Person.
“Transfer” has the meaning set out in Section 4.5(a).
“Transfer/Voting Ownership Threshold” has the meaning set out in Section 4.5(a).
“TSX” means the Toronto Stock Exchange or any successor thereto.
| -8- |
“United States” means the United States of America, its territories and possessions, any State of the United States and the District of Columbia.
“U.S. Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
“U.S. Securities Act” means the United States Securities Act of 1933, as amended.
“U.S. Securities Laws” has the meaning set out in Section 4.9(l).
| 1.2 | Certain Rules of Interpretation |
In this Agreement, unless otherwise specifically provided or unless the context otherwise requires:
| (a) | the terms “Agreement”, “this Agreement”, “the Agreement”, “hereto”, “hereof”, “herein”, “hereby”, “hereunder” and similar expressions refer to this Agreement in its entirety and not to any particular provision hereof; |
| (b) | references to a “clause”, “Section” or “Article” followed by a number or letter refer to the specified clause, Section or Article of this Agreement; |
| (c) | the division of this Agreement into articles and sections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement; |
| (d) | words importing the singular shall include the plural and vice versa, and words importing gender shall include all genders; |
| (e) | the words “including”, “includes” and “include” shall be deemed to be followed by the words “without limitation”; |
| (f) | the terms “party” and “the parties” refer to a party or the parties to this Agreement, and references to a party in this Agreement mean such party or its successors or permitted assigns; |
| (g) | references to agreements (including this Agreement) and other contractual instruments shall be deemed to include all subsequent amendments and other modifications thereto, but only to the extent such amendments and other modifications are not prohibited by the terms of this Agreement; |
| (h) | references to statutes or regulations are to be construed as including all statutory and regulatory provisions consolidating, amending, supplementing, interpreting or replacing the statute or regulation referred to; and |
| (i) | whenever any payment is required to be made, action is required to be taken or period of time is to expire on a day other than a Business Day, the date on which such payment shall be made, action shall be taken or period shall expire shall be the next following Business Day. |
| -9- |
| 1.3 | Control |
The term “control” (including, with correlative meanings, the terms “controlled by” and “under common control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership of voting securities, by contract or otherwise.
| 1.4 | Currency |
All references in this Agreement to currency or to “$”, unless otherwise expressly indicated, shall be to United States dollars. All references in this Agreement to “C$” shall be to Canadian dollars.
| 1.5 | Time of Essence |
Time shall be of the essence of this Agreement.
| 1.6 | Knowledge |
For the purposes of this Agreement, with respect to any matter, the knowledge of the Company shall mean the actual knowledge of the Chief Executive Officer or the Chief Financial Officer of the Company and all information which ought to have been known by any of them after conducting a reasonable inquiry into the matters in question, whether or not any such inquiry was actually made.
Article 2
SUBSCRIPTION FOR PURCHASED SECURITIES
| 2.1 | Subscription for Purchased Securities |
| (a) | Subject to the terms and conditions of this Agreement, the Investor hereby subscribes for and agrees to purchase the Purchased Securities from the Company on the Closing Date, and the Company hereby accepts such subscription and agrees to issue the Purchased Securities from treasury and sell the Purchased Securities to the Investor on such date, for an aggregate subscription price equal to the Subscription Proceeds. |
| (b) | Subject to the satisfaction or waiver of the terms and conditions of this Agreement, at the Closing Time, the Investor shall pay, or cause to be paid to the Company, in full satisfaction of the aggregate subscription price for the Purchased Securities, the Subscription Proceeds, by wire transfer in immediately available funds to the following account: |
| Beneficiary: | [REDACTED – BANK ACCOUNT INFORMATION] |
| Beneficiary address: | |
| -10- |
| Beneficiary Bank: | [REDACTED – BANK ACCOUNT INFORMATION] |
| Bank/FI number: | [REDACTED – BANK ACCOUNT INFORMATION] |
| Bank address: | |
| Beneficiary Account number: | [REDACTED – BANK ACCOUNT INFORMATION] |
| Branch/Transit number: | |
| SWIFT: | |
| ABA number: | [REDACTED – BANK ACCOUNT INFORMATION] |
| U.S. Corresponding Bank: | |
| X.X. Xxxxxx Swift Code: |
Article 3
REPRESENTATIONS AND WARRANTIES
| 3.1 | Representations and Warranties of the Company |
The Company, acknowledging that the Investor is entering into this Agreement in reliance thereon, hereby represents and warrants to the Investor as of the date hereof as follows:
| (a) | Organization and Powers. Each of the Company and its Subsidiaries: (i) has been duly incorporated and is validly existing under the laws of its jurisdiction of incorporation or organization; (ii) has all requisite corporate power and authority to own and lease its property and assets and to carry on its business; and (iii) has all requisite corporate power and authority to enter into this Agreement and to perform its obligations hereunder. |
| (b) | Authorization; No Conflict. The execution and delivery by the Company of this Agreement, and the performance by it of its obligations hereunder, have been duly authorized by all necessary corporate action on its part and do not and will not: (i) contravene any provision of its constating documents or any resolution of its shareholders or directors (or any committee thereof); or (ii) assuming receipt of the Chinese Approvals, violate any Applicable Law. |
| (c) | Execution; Binding Obligation. This Agreement has been duly executed and delivered by the Company and constitutes a legal, valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except to the extent enforcement may be affected by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Applicable Laws affecting creditors’ rights generally and subject to the qualification that equitable remedies may be granted in the discretion of a court of competent jurisdiction. |
| (d) | Consents. Neither the Company nor any of its Subsidiaries is required to give any notice to, make any filing with or obtain any Authorization, Order or other approval of any Person in connection with the execution or delivery by the Company of or performance of its obligations under this Agreement, other than (i) any filings, consents or notices required by Securities Laws, (ii) notice to GM in connection with its pre-emptive right pursuant to the GM Agreement, (iii) notices required to be delivered under the EDC Warrants and Lender Warrants to the holders thereof, (iv) the Chinese Approvals, or (v) where the failure to give any notice to, make any filing with or obtain any Authorization, Order or other approval of any Person in connection with the execution or delivery of or performance of its obligations under this Agreement would not, in the aggregate, have a material adverse effect on the Company. |
| -11- |
| (e) | Authorized and Issued Capital. The authorized capital of the Company consists of an unlimited number of Common Shares and an unlimited number of preference shares, of which 12,549,163 Common Shares have been validly issued and are outstanding as of the date hereof and no preferred shares have been issued or are outstanding as of the date hereof. All of the issued and outstanding Common Shares are fully paid and non-assessable and have been duly authorized by all necessary corporate action and issued. Except (i) pursuant to the GM Agreement, (ii) the 200,575 warrants issued to Export Development Canada on November 4, 2016 (the “EDC Warrants”), (iii) the 250,000 warrants issued to a syndicate of lenders on May 6, 2015 (the “Lender Warrants”), and (iv) for Common Shares issuable to directors, officers, employees and consultants pursuant to outstanding options, warrants, share incentive plans, convertible, exercisable and exchangeable securities, employment agreements and other rights to acquire Common Shares, no person has any agreement with the Company or any privilege, warrant, convertible security or option exercisable against the Company or any right capable of becoming an agreement with the Company for the purchase, subscription or issuance of any unissued Common Shares or any other securities of the Company. | |
| (f) | Listing of Common Shares. The Outstanding Common Shares as of the date hereof are listed and posted for trading on the TSX and the NASDAQ and no order ceasing or suspending trading in any securities of the Company or prohibiting the sale or issuance of the Purchased Securities or the trading of any of the Company’s issued securities has been issued and no proceedings for such purpose are pending or, to the knowledge of the Company, have been threatened. |
| (g) | Issuance of Purchased Securities. The Company has the full power and authority to issue the Purchased Securities. The issuance of the Purchased Securities has, or prior to the Closing Date will be, duly authorized by all necessary corporate action and, when issued against payment of the Subscription Proceeds therefor, the Purchased Securities will be validly issued as fully paid and non-assessable Common Shares in the capital of the Company. At the Closing Time, the Investor will be the legal owner of the Purchased Securities and will have good title thereto free and clear of all Encumbrances, other than pursuant to this Agreement and as may be imposed as a result of the application of any Applicable Laws or as are imposed as a result of any actions taken by, or transactions entered into by, the Investor. |
| (h) | Regulatory and Other Compliance. The Company is a “reporting issuer” (or the equivalent) in each of the provinces of Canada and is not included on a list of defaulting reporting issuers maintained by the Securities Regulators. The Company has not taken any action to cease to be a reporting issuer in any jurisdiction in which it is a reporting issuer, and has not received any notification from a Securities Regulator seeking to revoke the Company’s reporting issuer status. The Company is a “foreign private issuer” as defined in Rule 405 under the U.S. Securities Act and in Rule 3b-4 under the U.S. Exchange Act. |
| -12- |
| (i) | U.S. Securities Law. None of the Company, any of its Affiliates or any other Person acting on its or their behalf has engaged in “directed selling efforts” within the meaning of Regulation S of the U.S. Securities Act. The Company is not and, after giving effect to the offer and sale of the Purchased Securities and the application of the proceeds thereof, will not be required to be registered as an “investment company” pursuant to the Investment Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder. Assuming the accuracy of the Investor’s representations and warranties contained herein, no registration under the U.S. Securities Act of the Purchased Securities is required for the offer and sale of the Purchased Securities by the Company to the Investor. |
| (j) | Public Disclosure Documents. As of the time it was filed, each of the Public Disclosure Documents complied in all material respects with the applicable requirements of Securities Laws and none of the Public Disclosure Documents contained any untrue statement of material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements contained therein, in light of the circumstances under which they were made, not misleading, except to the extent any such Public Disclosure Document is superseded by a subsequent Public Disclosure Document. The Company has not filed any confidential material change report or other confidential report with any Securities Regulator which at the date hereof remains confidential. Subject to the satisfaction of the conditions to closing set forth in Article 5, the accuracy of the representations and warranties of the Investor in this Agreement and provided that the Company obtains the conditional listing approval of the TSX and the NASDAQ for the Purchased Securities and that the Chinese Approvals are obtained, the Company has complied with all applicable corporate laws and Securities Laws and rules of any exchange on which any securities of the Company are listed where such rules are applicable to it in connection with the offer, sale and issuance of Purchased Securities. |
| (k) | Intellectual Property. The Company or one or more of its Subsidiaries is the owner of all right, title and interest in, or has a valid and enforceable right to use, the material intellectual property used in its business, free and clear of any Encumbrances, and any Intellectual Property license agreements granted to the Company or one or more of its Subsidiaries by a third party used in its business, are in good standing. The Company or one or more of its Subsidiaries has a valid and enforceable right to use and otherwise exploit the Intellectual Property in all jurisdictions in which it is currently used or otherwise exploited. The Company or one or more of its Subsidiaries has obtained sufficient and enforceable moral rights waivers from all authors of any works of authorship that are included in the Intellectual Property that is owned by the Company or one or more of its Subsidiaries such that the Company is not limited in any way in which it may choose to commercialize, exploit, use, adapt, modify, improve, associate or otherwise deal with such works of authorship and no consents, permissions, or approvals are required by the Company in that regard. Other than what has been expressly disclosed to the Investor, as of the date hereof the Company has not received any notice of any pending or threatened actions, suits or proceedings alleging: the infringement, misappropriation, misuse or violation of any Intellectual Property Rights or other right of any third party or breach of any duty or obligation owed to any third party. |
| -13- |
| 3.2 | Representations and Warranties of the Investor |
The Investor, acknowledging that the Company is entering into this Agreement in reliance thereon, hereby represents and warrants to the Company as of the date hereof as follows:
| (a) | Organization and Powers. The Investor: (i) has been duly organized and is validly existing under the laws of its jurisdiction of organization; and (ii) has all requisite limited partnership power and authority to enter into this Agreement and to perform its obligations hereunder. |
| (b) | Authorization; No Conflict. The execution and delivery by the Investor of this Agreement, and the performance by it of its obligations hereunder, have been duly authorized by all necessary corporate or other action on its part or on the part of its general partner and do not and will not: (i) contravene any provision of its constating documents or any resolution of its partners, or any of the shareholders or directors thereof (or any committee thereof) as applicable; (ii) violate any Applicable Law; or (iii) cause the Company or any of its directors or officers to become subject to any continuous disclosure or similar reporting requirements under the laws of China, or require any disclosure, prospectus or other similar offering document to be prepared, filed or delivered by the Company under the laws of China. |
| (c) | Execution; Binding Obligation. This Agreement has been duly executed and delivered by the Investor, and constitutes a legal, valid and binding agreement of the Investor, enforceable against the Investor in accordance with its terms, except to the extent enforcement may be affected by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Applicable Laws affecting creditors’ rights generally and subject to the qualification that equitable remedies may be granted in the discretion of a court of competent jurisdiction. |
| (d) | Acting Jointly or In Concert. The Investor is not Acting Jointly or In Concert with any other Person. |
| (e) | Consents. The Investor is not required to give any notice to, make any filing with or obtain any Authorization, Order or other approval of any Person in connection with the execution or delivery of or performance of its obligations under this Agreement. |
| -14- |
| (f) | Ownership of Common Shares. As of the date of this Agreement, the Investor (i) does not beneficially own any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares and does not have any right or obligation permitting or requiring the Investor, whether or not on conditions, to acquire beneficial ownership of Common Shares and (ii) is not Acting Jointly or In Concert with any Person who owns any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares or has any right or obligation permitting or requiring such Person, whether or not on conditions, to acquire beneficial ownership of Common Shares. |
| (g) | Anti-Money Laundering. The funds representing the Subscription Proceeds which will be advanced by the Investor to the Company hereunder will not represent proceeds of crime for the purposes of PCMLA and the Investor acknowledges that the Company may in the future be required by law to disclose the Investor’s name and other information relating to this Agreement, on a confidential basis, to required Governmental Bodies pursuant to the PCMLA. To the Investor’s knowledge, none of the funds representing the Subscription Proceeds to be provided by the Investor: (i) have been or will be derived from or related to any activity that is deemed criminal under Applicable Laws of Canada, the United States or any other jurisdiction; or (ii) are being tendered on behalf of a Person or entity who has not been identified to the Investor; and the Investor shall promptly notify the Company if it discovers that any of such representations ceases to be true, and will provide the Company with appropriate information in connection therewith. |
| (h) | Financing. The Investor has, and will have at the Closing Time, sufficient funds to purchase the Purchased Securities. |
| 3.3 | Survival of Representations and Warranties |
The representations and warranties of a party in this Article 3 and in all certificates and documents delivered pursuant to or as contemplated by this Agreement shall not survive the Closing Date. For greater certainty, this Section 3.3 shall not limit any covenant or agreement of the parties that, by its terms, contemplates obligations following the Closing Date.
Article 4
COVENANTS AND Agreements
| 4.1 | Mutual Covenants Regarding Closing |
Each of the parties shall use commercially reasonable efforts to take all actions as are within its power to control, and to cause other actions to be taken that are not within its power to control, so as to ensure the satisfaction of each of the conditions and covenants set forth in Sections 5.2 and 5.3, which are for the benefit of any other party.
| -15- |
| 4.2 | Other Covenants of the Company |
| (a) | The Company shall fulfill all necessary requirements and take all necessary action required to be taken by the Company to permit the creation, issuance and delivery by the Company of the Purchased Securities to the Investor as fully-paid and non-assessable Common Shares pursuant to an exemption from the prospectus requirements of applicable Securities Laws. |
| (b) | Forthwith after Closing, the Company shall take all required action to satisfy the conditions set out in the conditional acceptance of the TSX for the listing of the Purchased Securities, and in any event within the time period prescribed by the TSX, to satisfy such conditions. |
| (c) | [REDACTED – COMMERCIALLY SENSITIVE INFORMATION] |
| 4.3 | Pre-Emptive Rights |
| (a) | In the event that the Company proposes to sell or issue any Common Shares or securities convertible or exchangeable into Common Shares of the Company (collectively, the “Offered Securities”), other than pursuant to an Excluded Issuance, (an “Offering”) the Investor shall have the right (the “Pre-Emptive Right”) to participate in such Offering and acquire in such Offering (on an unregistered and private placement basis) for cash at the subscription price payable by all participants in the Offering, or at the lowest price payable by any participant in the Offering in the case of an Offering in which all of the participants do not pay the same subscription price, such number of the Offered Securities necessary in order to maintain the Investor’s percentage ownership interest of Outstanding Common Shares following completion of the Offering that is the same as the percentage ownership of Outstanding Common Shares owned by the Investor immediately prior to giving effect to such Offering. The exercise of the Pre-Emptive Right shall be subject to the satisfaction of applicable TSX and NASDAQ requirements (which the Company shall use reasonable efforts to obtain) and Chinese regulatory approvals in respect of the Offering and the remittance of the consideration for the Offered Securities out of China (which the Investor shall use reasonable efforts to obtain). | |
| (b) | Within five (5) Business Days of entering into a letter of intent or term sheet with respect to an Offering, or within five (5) Business Days of entering into a definitive agreement with respect to an Offering if no letter of intent or term sheet is entered into with respect to such Offering, the Company shall provide written notice to the Investor specifying the terms and conditions of such Offering, including a description of the Offered Securities, the subscription price or range of subscription prices therefor set out in the letter of intent, term sheet or definitive agreement and the proposed closing date for the issuance of Offered Securities (the “Pre-Emptive Right Offer Notice”). |
| -16- |
| (c) | The Investor shall have five (5) Business Days (the “Pre-Emptive Right Offer Period”) after receiving the Pre-Emptive Right Offer Notice to exercise the Pre-Emptive Right. If no notice of acceptance is received by the Company within the Pre-Emptive Right Offer Period, the Investor shall be deemed to have rejected the Pre-Emptive Right Offer Notice. |
| (d) | The completion of an Offering under this Section 4.3 shall take place on the later of (a) the 5th Business Day after the expiry of the Pre-Emptive Right Offer Period and (b) the date of the completion of such Offering (the “Pre-Emptive Right Closing Date”). Notwithstanding the foregoing, if the Investor has not obtained all necessary Chinese regulatory approvals in respect of the Offering for the remittance of the consideration for the Offered Securities out of China by the Pre-Emptive Rights Closing Date, then the Company may complete the Offering without issuing any Offered Securities to the Investor upon completion of the Offering, provided that if the Investor obtains such approvals within fifteen (15) Business Days after the Pre-Emptive Rights Closing Date (the “Approval Deadline”) then the Company shall issue the Offered Securities to which the Investor is entitled on exercise of its Pre-Emptive Right as soon as reasonably practicable after receipt of such approvals. If such approvals are not obtained by the Approval Deadline, then the Investor will be deemed to have rejected the Pre-Emptive Right Offer Notice. |
| (e) | Notwithstanding the foregoing, the Pre-Emptive Right shall not apply if the exercise of the Pre-Emptive Right by the Investor would require the Company to obtain approval of the Company’s shareholders pursuant to Applicable Laws, provided that in such case the Pre-Emptive Right shall apply to the maximum number of Common Shares that the Company is able to issue to the Investor without obtaining approval of the Company’s shareholders pursuant to Applicable Laws. | |
| (f) | The Pre-Emptive Right shall cease to apply, on the expiry of a consecutive thirty (30) day period from the date the Investor ceases to own five percent (5%) or more of the Outstanding Common Shares (the “Pre-Emptive Right Ownership Threshold”). |
| 4.4 | Board Representation |
| (a) | Until the Investor ceases to own more than ten percent (10%) of the Outstanding Common Shares (the “Nominee Right Threshold”) either (i) for a period in excess of thirty (30) days or (ii) more than once in any one-year period, the Investor shall be entitled to nominate, by written notice to the Company (an “Investor Nominee Notice”) one individual to be appointed to the Board (the “Investor Nominee”). Each Investor Nominee shall, prior to his or her appointment to the Board, provide all information and sign all documents required to be provided and signed pursuant to applicable Securities Laws and shall be required to meet the individual qualification requirements for directors under Applicable Law (the “Legal Qualification Requirement”) and be approved by the Company (together with the Legal Qualification Requirement, the “Qualification Requirements”). In connection with the foregoing, if and for so long as the Investor is entitled to nominate an Investor Nominee: |
| -17- |
| (i) | at the annual meeting of shareholders of the Company to be held in 2018 and at each subsequent meeting of shareholders on the Company thereafter at which directors are to be elected, the Company shall cause the Investor Nominee to be included in the slate of nominees proposed by the Company to the shareholders of the Company for election as directors; |
| (ii) | the Company shall use commercially reasonable efforts to cause the election of each Investor Nominee, including recommending that shareholders of the Company vote in favour of the election of, and soliciting proxies in favour of the election of, the Investor Nominee; |
| (iii) | the Company shall provide written notice to the Investor of any: (A) annual meeting of the shareholders of the Company at which directors of the Company are to be elected at least sixty (60) days prior to the date of such annual meeting of shareholders of the Company and (B) in the case of a special meeting (which is not also an annual meeting) of shareholders of the Company called for the purpose of electing directors (whether or not called for other purposes), as soon as practicable, and, in any event, at the earlier of the date that a notice of meeting is filed for such meeting or the date on which the first public announcement of the date of such meeting was made; |
| (iv) | an Investor Nominee Notice must be received by the Company: |
| (A) | in the case of an annual meeting of shareholders of the Company, not less than fifty (50) days prior to the date of such annual meeting of shareholders of the Company; provided, however, that in the event that the annual meeting of shareholders of the Company is to be held on a date that is less than fifty (50) days after the date (the “Investor Nominee Notice Date”) that is the earlier of the date that a notice of meeting is filed for such meeting or the date on which the first public announcement of the date of the annual meeting was made, an Investor Nominee Notice must be received by the Company no later than the close of business on the tenth (10th) day following the Investor Nominee Notice Date; and |
| (B) | in the case of a special meeting (which is not also an annual meeting) of shareholders of the Company called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the tenth (10th) day following the day that is the earlier of the date that a notice of meeting is filed for such meeting or the date on which the first public announcement of the date of such meeting was made, but in any event no later than ten (10) days preceding the date on which the Company is required by Securities Law to mail a management information circular in respect of the meeting, provided that the Company shall have notified the Investor of such date as soon as practicable. |
| -18- |
In no event shall any adjournment or postponement of a meeting of shareholders of the Company or the announcement thereof commence a new time period for the delivery or mailing of an Investor Nominee Notice as described in this Section 4.4(a)(iv).
| (v) | notwithstanding anything to the contrary herein, if the Investor does not advise the Company of its Investor Nominee within the time set forth in Section 4.4(a)(iv), then the Company shall not be required to include the Investor Nominee in the slate of nominees proposed by the Company to the shareholders of the Company for election as directors at the relevant meeting of shareholders; |
| (vi) | if the Investor Nominee ceases to satisfy the Qualification Requirements, at the request of the majority of the members of the Board, the Investor Nominee shall resign from the Board effective immediately; |
| (vii) | if an Investor Nominee ceases to hold office as a director of the Company for any reason (unless the Investor is not entitled to appoint an Investor Nominee pursuant to Section 4.4(a)), including if the Investor Nominee ceases to satisfy the Qualification Requirements, the Investor shall be entitled to nominate an individual that satisfies the Qualification Requirements to replace him or her as a new Investor Nominee and the Company shall promptly take all steps as may be necessary to appoint such individual to the Board to replace an Investor Nominee who has ceased to hold office; |
| (viii) | the Investor Nominee Notice and any other notice proposing a nominee shall contain sufficient information to allow the Company to determine whether the proposed nominee satisfies the Legal Qualification Requirement and, prior to nominating an Investor Nominee, the Investor will give due consideration to the view of the independent members of the Board as to whether such person is an appropriate addition to the Board given his or her skill set; |
| (ix) | the Investor Nominee shall be provided with equivalent indemnification from the Company and directors’ insurance as the other members of the Board; |
| (x) | the Company shall maintain directors’ insurance coverage that is appropriate in form and substance for companies similar to the Company in the jurisdictions in which the Company operates; and |
| -19- |
| (xi) | the Investor Nominee shall be provided with notice of Board meetings as is required to be given to Board members under the constating documents of the Company. |
| (b) | The Investor acknowledges and agrees that the Investor Nominee may be excluded from meetings of the Board or applicable portions thereof in the event of actual or potential conflicts of interest, as and to the extent determined by the Board, acting reasonably. |
| (c) | The Investor shall forthwith notify the Company in writing if the Investor ceases to hold the Nominee Right Threshold. At the request of the Company at any point after the Investor ceases to be entitled to appoint an Investor Nominee pursuant to Section 4.4(a), the Investor Nominee shall resign from the Board, effective immediately and the Investor shall have no further right hereunder to designate an Investor Nominee and the Company shall cease to have any obligations pursuant to this Section 4.4. In determining whether it holds the Nominee Right Threshold, the Investor is entitled to rely on the number of Outstanding Common Shares most recently disclosed in the disclosure documents filed by the Company with the Securities Regulators that are available on SEDAR and XXXXX unless the Investor has actual knowledge that the number of Outstanding Common Shares is different from such disclosed number. |
| (d) | Upon an Investor Nominee joining the Board, he or she shall sign an undertaking whereby he or she will offer his or her resignation from the Board in the circumstances mentioned in Sections 4.4(a)(vi) and 4.4(c). |
| (e) | Subject to Applicable Law and provided that the Investor is entitled to appoint an Investor Nominee pursuant to Section 4.4(a), the Board shall use commercially reasonable efforts to cause the appointment of the initial Investor Nominee to the Board as soon as reasonably practicable following the later of (i) the date of the Corporation’s receipt of an Investor Nominee Notice in respect of the initial Investor Nominee, (ii) the Closing Date and (iii) the annual meeting of the shareholders of the Company scheduled to be held on May 12, 2017 or adjournment or postponement thereof, and, upon such appointment, the initial Investor Nominee shall be entitled to serve on the Board until the annual meeting of shareholders of the Company at which directors of the Company are to be elected in 2018. |
| 4.5 | Transfer Restrictions and Voting Matters |
| (a) | From and after the Closing Date and for so long as the Investor Group Parties beneficially own Common Shares representing five percent (5%) or more of the Outstanding Common Shares (the “Transfer/Voting Ownership Threshold”), the Investor covenants and agrees that it shall not, directly or indirectly, including through any Affiliate, Associate, officer, director, agent or otherwise, in any single transaction or series of related transactions, without the prior written consent of, or waiver by, the Company, (i) offer to sell, sell, assign, pledge, hypothecate, gift or otherwise transfer or dispose of in any manner whatsoever (or enter into any contract or other obligation regarding any future offer to sell, sale, assignment, pledge, hypothecation. gift or transfer or disposition in any manner whatsoever of) beneficial ownership of (each, a “Transfer”) any Common Shares, other than pursuant to a Permitted Pledge, (ii) enter into any derivative instrument, hedging arrangement or other similar agreement or arrangement that transfers in whole or in part, the economic risk of ownership of any Common Shares, other than pursuant to a Permitted Pledge (iii) engage in any short selling of Common Shares, or (iv) make any public or private disclosure of any consideration, intention, plan or arrangement inconsistent with any of the foregoing; other than, in the case of (i) above, pursuant to a Permitted Transfer. | |
| -20- |
| (b) | From and after the Closing Date until the expiry of the Restricted Period, the Investor covenants and agrees that it will cause all of the Common Shares beneficially owned by the Investor Group Parties not to be voted (1) against or withheld, as the case may be, from voting in respect of all those persons nominated and publicly recommended by the Company to serve as directors of the Board, and (2) with respect to any other action, proposal or matter to be voted on by the shareholders of the Company (including through action by written consent), against the public recommendation of a unanimous Board (excluding (i) directors who have abstained from voting for reasons of conflict of interest and (ii) the Investor Nominee). For greater certainty, the Investor may (x) abstain from voting in any matter to be voted on by the shareholders of the Company or (y) vote its Common Shares at its own discretion, if the public recommendation of the Board is not unanimous (excluding (i) directors who have abstained from voting for reasons of conflict of interest and (ii) the Investor Nominee). | |
| (c) | The certificates representing the Purchased Securities shall contain upon their face or upon the reverse side thereof a legend to the following effect: | |
| “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER OF THE SECURITIES SHALL NOT TRADE THE SECURITIES BEFORE THE DAY THAT IS ONE YEAR AFTER THE DATE HEREOF. THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE LISTED ON THE TORONTO STOCK EXCHANGE, HOWEVER, THE SAID SECURITIES CANNOT BE TRADED THROUGH THE FACILITIES OF THE TORONTO STOCK EXCHANGE SINCE THEY ARE NOT FREELY TRANSFERABLE AND CONSEQUENTLY DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE “GOOD DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON THE TORONTO STOCK EXCHANGE. A NEW CERTIFICATE, BEARING NO LEGEND, (DELIVERY OF WHICH WILL CONSTITUTE “GOOD DELIVERY” ON THE TORONTO STOCK EXCHANGE) MAY BE OBTAINED FROM CST TRUST COMPANY UPON DELIVERY OF THIS CERTIFICATE.” |
| -21- |
| 4.6 | Standstill |
| (a) | For so long as the Investor Group Parties beneficially own the Transfer/Voting Ownership Threshold, the Investor shall not and shall cause each of the Investor Group Parties and their respective officers, directors and agents, not to, without the prior written consent of the Company: |
| (i) | in any manner acquire, agree to acquire or make to securityholders of the Company any offer to acquire, directly or indirectly, any securities of the Company; |
| (ii) | propose or offer to enter into, directly or indirectly, any amalgamation, plan of arrangement, merger or business combination involving the Company or its Subsidiaries or to purchase, directly or indirectly, a material portion of the property or assets of the Company or its Subsidiaries; |
| (iii) | directly or indirectly “solicit” or participate or join with any person in the “solicitation” of any “proxies” (as such terms are defined in the Securities Act (Ontario)) to vote, or seek to influence any person with respect to the voting of, any Common Shares or other securities of the Company; |
| (iv) | other than with respect to the Investor Nominee, seek (i) representation on the Board, (ii) the removal of any directors on the Board, or (iii) a change in the size or composition of the Board; |
| (v) | otherwise act alone or Act Jointly or In Concert with others, subject to the Investor Nominee performing his or her duties as a director of the Company, to seek to control or to influence the management, the Board or policies of the Company; |
| (vi) | make any public or private disclosure of any consideration, intention, plan or arrangement inconsistent with any of the foregoing; or |
| (vii) | advise, assist, encourage or Act Jointly or In Concert with any other Person in connection with any of the foregoing. |
| 4.7 | Strategic Chinese Market Development |
As soon as practicable following the Closing Date, the Investor shall incorporate a dedicated Chinese project company (“NewCo”). NewCo will cooperate with the Company to jointly develop the Chinese market for hydrogen generation, energy storage and fuel cell products. The Investor shall, or shall cause NewCo to, promptly following a written request from the Company, reimburse the Company for any reasonable travel or other expenses incurred and documented by employees of the Company in connection with providing technical support to NewCo.
| -22- |
| 4.8 | Regulatory Matters |
The Investor will execute, deliver and file or reasonably assist the Company in filing such reports, undertakings and other documents with respect to the transactions contemplated hereby as may be required by Securities Regulators, including but not limited to personal information forms, early warning reports and insider reports. The Company and its legal counsel shall be given a reasonable opportunity to review and comment on such reports, undertakings and other such documents delivered or filed by the Investor prior to their delivery or filing. The Investor shall submit a completed personal information form as required by the TSX as soon as reasonably practicable after the date of this Agreement, and in any event within seven (7) Business Days after the date of this Agreement, and shall deliver to the Company any additional information required by the TSX relating to the Investor or the Investor Nominee within seven (7) Business Days after the Company notifies the Investor of such request.
| 4.9 | Securities Law Acknowledgements |
The Investor, acknowledging that the Company is entering into this Agreement in reliance thereon, hereby acknowledges the following:
| (a) | The Company is relying on an exemption from the requirement to provide the Investor with a prospectus under Securities Laws and, as a consequence of acquiring any of the Purchased Securities pursuant to such exemption, certain protections, rights and remedies provided by Securities Laws, including statutory rights of rescission or damages, will not be available to the Investor, and the Investor may not receive information that would otherwise be required to be provided to it under Securities Laws. |
| (b) | The Investor has not been provided with an offering memorandum or sales literature (as such terms are defined in any Securities Laws) or any similar document in connection with its subscription for the Purchased Securities, and the decision to execute this Agreement and to purchase the Purchased Securities has not been based upon any verbal or written representations as to fact or otherwise made by or on behalf of the Company, other than such written representations as are expressly contained in this Agreement or as may be set forth in the Public Disclosure Documents. |
| (c) | The Investor has not relied, is not relying and will not rely on the Company with respect to financial, tax or other economic considerations of an investment in the Purchased Securities and the Investor has relied on the advice of, or has consulted with, only the Investor’s own advisors. |
| (d) | The Investor has had a reasonable opportunity to ask questions of and receive answers from Persons acting on behalf of the Company concerning the Purchased Securities and the business of the Company and all such questions and requests for information and other materials have been answered and provided to the satisfaction of the Investor. |
| -23- |
| (e) | No United States federal or state agency or Canadian provincial or territorial or any other governmental agency has passed upon or made any recommendation or endorsement of the Purchased Securities. |
| (f) | There is no government or other insurance covering the Purchased Securities. |
| (g) | There are risks associated with the purchase of the Purchased Securities. |
| (h) | The Investor has obtained independent legal advice from counsel with respect to its investment in the Purchased Securities. |
| (i) | The Investor is aware, and it will advise its partners and Affiliates and its and their respective directors, officers and employees, that Securities Laws impose certain restrictions with respect to the communication of material non-public information and with respect to the purchase and sale of securities of a “reporting issuer” (as such term is defined under the applicable Securities Laws) by a person who has received material non-public information, and it hereby agrees to abide by all applicable Securities Laws. |
| (j) | The Investor is not purchasing the Purchased Securities as a result of any “general solicitation” or “general advertising”, as those terms are used in Regulation D under the U.S. Securities Act including, without limitation, advertisements, articles, notices and other communications published in any newspaper, magazine or similar media or broadcast over television or radio or any seminar or meeting whose attendees have been invited by “general solicitation” or “general advertising”. |
| (k) | The Purchased Securities are being offered for sale on a “private placement” basis and the Purchased Securities will be subject to contractual resale restrictions and statutory resale restrictions under Securities Laws. The Investor acknowledges that the certificates representing the Purchased Securities will bear the legend specified in s. 4.5(c) with respect to such resale restrictions. |
| (l) | The Purchased Securities have not been and will not be registered under the U.S. Securities Act or the securities laws of any state of the United States (collectively, the “U.S. Securities Laws”) and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as such terms are defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act or an exemption from the registration requirements of the U.S. Securities Act is available. |
| (m) | The Company (i) has informed the Investor that it is not obligated to file and has no present intention of filing, and (ii) will not be filing, in each case, with any of the Securities Regulators or with any state securities administrator any prospectus or registration statement in respect of resales of the Purchased Securities in Canada or the United States. |
| -24- |
| (n) | The Investor consents to: (i) the fact that the Company is collecting “personal information” (as that term is defined under applicable privacy legislation, including, without limitation, the Personal Information Protection and Electronic Documents Act (Canada) and any other applicable similar, replacement or supplemental provincial or federal legislation or laws in effect from time to time); (ii) the Company retaining such Personal information for as long as permitted or required by Applicable Law or business practices; (iii) the fact that the Company may be required by Securities Laws, the rules and policies of any stock exchange or the rules of the Investment Industry Regulatory Organization of Canada to provide Securities Regulators or other Governmental Bodies with any “personal information” provided by the Investor in or in connection with this Agreement; and (iv) the collection, use and disclosure of the Investor’s “personal information” by the TSX. |
| (o) | The Company has notified the Investor that (i) the Company is required to provide information (“Personal Information”) pertaining to the Investor required to be disclosed in Schedule I of Form 45-106F1 under NI 45-106 (including its name, address, telephone number and the number of Purchased Securities subscribed for), which Form 45-106F1 is required to be filed by the Company under NI 45-106, (ii) the Personal Information will be delivered to the applicable members of the CSA in accordance with NI 45-106, (iii) such Personal Information is being collected indirectly by the CSA under the authority granted to it in securities legislation, (iv) such Personal Information is being collected for the purposes of the administration and enforcement of the applicable Securities Laws, and (v) the public official in each province of Canada who can answer questions about the indirect collection of such personal information is set forth in Exhibit A. By executing this Agreement, the Investor has authorized the indirect collection of such Personal Information by the applicable members of the CSA and acknowledges that its name, address, telephone number and other specified information, may be shared and disclosed among all members of the CSA and may become available to the public in accordance with the requirements of applicable legislation and consents to the disclosure of such information. |
| 4.10 | Securities Law Representations and Warranties |
The Investor, acknowledging that the Company is entering into this Agreement in reliance thereon, hereby represents and warrants to the Company as of the date hereof, and as of the Closing Date, as follows:
| (a) | The Investor is purchasing the Purchased Securities as principal and is an “accredited investor” within the meaning of National Instrument 45-106 – Prospectus Exemptions by virtue of being a partnership that has net assets of at least C$5,000,000 as shown in its most recently prepared financial statements. |
| (b) | The Investor was not created, and is not being used, solely to purchase and hold securities in reliance on an exemption from prospectus and registration requirements under Securities Laws. |
| -25- |
| (c) | The Investor is purchasing the Purchased Securities for investment purposes only and not with a view to resale or distribution of any of the Purchased Securities, and not in a transaction or series of transactions involving a purchase and sale or a repurchase and resale in the course of or incidental to a distribution. |
| (d) | The Investor is purchasing the Purchased Securities in compliance with all applicable securities laws of China, including any province or district thereof, and the issuance of the Purchased Securities to the Investor does not require the registration of the Purchased Securities or the filing of a prospectus or any similar document by the Company, or require the Company to take any other action, with respect to the Purchased Securities under the laws of China or any province or district thereof. |
| (e) | The Investor certifies that (a) the Investor is not a Canadian or United States resident nor acting for the account or benefit of a Canadian or United States resident; (b) the Purchased Securities were not offered to the Investor in Canada or the United States; (c) the Investor was, at the time of agreeing to purchase the Purchased Securities, and is, outside Canada and the United States; and (d) the Investor was not offered the Purchased Securities in Canada or the United States, the Investor is not a Canadian person or U.S. person (as defined in Regulation S under the U.S. Securities Act), the sale and purchase of the Purchased Securities, including the execution of this Agreement was, or is being, or will be, as the case may be, executed outside of Canada and the United States. |
| 4.11 | Covenants of the Investor Regarding Chinese Approvals |
The Investor shall use its best efforts to obtain the Chinese Approvals as soon as reasonably practicable following the date of this Agreement. The Investor shall provide copies of all relevant filings with or responses to Governmental Bodies that contain disclosure or discussions relating to the Company in connection with obtaining the Chinese Approvals, to the Company and its advisors prior to filing or responding and, if requested by the Company, consider in good faith all reasonable additions, deletions or changes suggested in connection therewith. The Investor shall promptly notify the Company of any communication to the Investor from any Governmental Body and permit the Company to review in advance, if practical, any proposed communication to any Governmental Body, and to the extent not practical to permit the Company to review in advance the Investor shall provide the Company with a copy of any such communication as soon as reasonably practical after it is sent to the Governmental Body. Whenever practical and provided it will not cause delays or impairment in obtaining Chinese Approvals, the Investor shall consult the Company in advance of its participation in any meeting with any Governmental Body in connection with obtaining the Chinese Approvals and, to the extent permitted by such Governmental Body, gives the Company the opportunity to attend and participate thereat. To the extent that the Company does not attend and participate in any such meeting, the Investor shall promptly after such meeting provide a summary of the proceedings of such meeting to the Company. The Investor shall not take any action that could or could reasonably be expect to have the effect of delaying, impairing or impeding the receipt of the Chinese Approvals. The Investor shall keep the Company reasonably informed of the status of the Chinese Approvals.
| -26- |
Article 5
CLOSING
| 5.1 | Closing |
| (a) | The Closing will take place at the offices of legal counsel to the Company, or such other location or in such other manner as the Company and the Investor may agree, at the Closing Time. |
| (b) | At the Closing, the Investor shall deliver, or cause to be delivered, to the Company: |
| (i) | a certificate from a duly authorized officer of the Investor certifying that: |
| (A) | the Investor has complied in all material respects with the covenants and agreements contained in this Agreement to be performed or caused to be performed by it at or prior to Closing; and |
| (B) | all of the representations and warranties made by the Investor in this Agreement are true and correct in all material respects on the Closing Date as if made on and as of the Closing Date (except to the extent such representations and warranties expressly relate to an earlier date, and in such case, shall be true and correct on and as of such earlier date); and |
| (ii) | payment of the Subscription Proceeds in accordance with Section 2.1(b). |
| (c) | At the Closing, the Company shall deliver, or cause to be delivered, to the Investor: |
| (i) | a certificate of good standing (or equivalent) with respect to the Company issued within two Business Days prior to the Closing Date; |
| (ii) | a certificate from a duly authorized officer of the Company certifying (i) the articles of the Company, (ii) the incumbency of signing officers of the Company, and (iii) the corporate resolutions of the Company approving the execution and delivery of, and performance of the Company’s obligations under, this Agreement; |
| (iii) | a certificate from the Chief Executive Officer and Chief Financial Officer of the Company certifying that: |
| (A) | the Company has complied in all material respects with the covenants and agreements contained in this Agreement to be performed or caused to be performed by it at or prior to Closing; and |
| -27- |
| (B) | all of the representations and warranties made by the Company in this Agreement are true and correct in all material respects on the Closing Date as if made on and as of the Closing Date (except to the extent such representations and warranties expressly relate to an earlier date, and in such case, shall be true and correct on and as of such earlier date); |
| (iv) | a legal opinion addressed to the Investor dated the Closing Date, from legal counsel to the Company (who may rely, as to matters of fact, on certificates of public officials and officers of the Company) that: |
| (A) | the Company is a corporation incorporated and existing under the Business Corporations Act (Canada) and has the corporate power and capacity to enter into and perform its obligations under of this Agreement; |
| (B) | the Company has taken all necessary corporate action to authorize the execution and performance by it of this Agreement; |
| (C) | this Agreement has been duly executed and delivered by the Company; |
| (D) | this Agreement constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms; |
| (E) | the execution and delivery by the Company of this Agreement and the performance of its obligations hereunder will not (i) contravene or result in a breach of or constitute a default under the articles or by-laws of the Company; or (ii) contravene any law or regulation of Ontario or the federal laws of Canada applicable therein; |
| (F) | no authorization, consent, permit or approval of, or other action by, or filing with or notice to, any governmental agency or authority, regulatory body, court, tribunal or other similar entity having jurisdiction is required in Ontario in connection with the execution and delivery by the Company of this Agreement; |
| (G) | all necessary corporate action has been taken by the Company to create and issue the Purchased Securities and upon their issuance by the Company, in accordance with the terms of this Agreement, and following receipt by the Company of the Subscription Proceeds, the Purchased Securities will be legal, valid and binding obligations of the Company enforceable against the Company in accordance with their terms; and |
| (H) | the issuance by the Company of the Purchased Securities in accordance with the terms of this Agreement is exempt from the prospectus requirements of Canadian Securities Laws, and no documents are required to be filed by the Company (other than customary private placement reports accompanied by requisite filing fees), proceedings taken or approvals, permits, consents or authorizations obtained under Canadian Securities Laws to permit such issuance; |
| -28- |
| (v) | evidence that the NASDAQ and the TSX shall have approved the listing of all the Purchased Securities, subject only to the satisfaction of customary conditions all of which may be satisfied by the Company without material cost or delay (the “Exchange Approvals”); and |
| (vi) | a certificate bearing the legend set out in s. 4.5(c) and duly executed by the Company representing the Purchased Securities registered in the name of the Investor (or as the Investor may otherwise direct, if being issued to be held with an investment dealer), and duly issued by the Company and registered in the share register of the Company in the name of the Investor or other nominee. |
| 5.2 | Conditions to Closing in Favour of the Company |
The obligations of the Company to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction at or prior to the Closing Time of each of the following conditions, which are for the exclusive benefit of, and may be waived in writing by, the Company:
| (a) | all representations and warranties of the Investor contained in this Agreement shall be true and correct on the date hereof and shall be true and correct in all material respects on the Closing Date as if made on and as the Closing Date (except to the extent such representations and warranties expressly relate to an earlier date, and in such case, shall be true and correct on and as of such earlier date); |
| (b) | the Investor shall have performed and complied in all material respects with all covenants and agreements required by this Agreement to be performed or complied with by it on or prior to Closing; |
| (c) | the Company shall have received evidence that the NASDAQ and the TSX shall have approved the listing of all the Purchased Securities, subject only to the satisfaction of customary conditions all of which may be satisfied by the Company without material cost or delay; |
| (d) | the Investor shall have made, or cause to be made, all of the deliveries set out in Section 5.1(b); |
| (e) | no preliminary or permanent injunction or other Order issued by a Governmental Body, and no statute, rule, regulation or executive order promulgated or enacted by a Governmental Body, which restrains, enjoins, prohibits or otherwise makes illegal the consummation of the transactions contemplated by this Agreement shall be in effect; |
| -29- |
| (f) | no Order having the effect of suspending the issuance or ceasing the trading of any of the Purchased Securities or the Outstanding Common Shares issued or made by any Governmental Body, Securities Regulator or stock exchange shall be in effect; |
| (g) | the Chinese Approvals have been granted; and |
| (h) | the issue and sale of the Purchased Securities shall be exempt from the prospectus requirements of the Securities Laws. |
| 5.3 | Conditions to Closing in Favour of the Investor |
The obligations of the Investor to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction at or prior to the Closing Time of each of the following conditions, which are for the exclusive benefit of, and may be waived in writing by, the Investor:
| (a) | all representations and warranties of the Company contained in this Agreement shall be true and correct on the date hereof and shall be true and correct in all material respects on the Closing Date as if made on and as the Closing Date (except to the extent such representations and warranties expressly relate to an earlier date, and in such case, shall be true and correct in all material respects on and as of such earlier date); |
| (b) | the Company shall have performed and complied in all material respects with all covenants and agreements required by this Agreement to be performed or complied with by it on or prior to Closing; |
| (c) | the Company shall have received evidence that the NASDAQ and the TSX shall have approved the listing of all the Purchased Securities, subject only to the satisfaction of customary conditions all of which may be satisfied by the Company without material cost or delay; |
| (d) | the Company shall have made, or cause to be made, all of the deliveries set out in Section 5.1(c); |
| (e) | no preliminary or permanent injunction or other Order issued by a Governmental Body, and no statute, rule, regulation or executive order promulgated or enacted by a Governmental Body, which restrains, enjoins, prohibits or otherwise makes illegal the consummation of the transactions contemplated by this Agreement shall be in effect; |
| (f) | no Order having the effect of suspending the issuance or ceasing the trading of any of the Purchased Securities issued or made by any Governmental Body, Securities Regulator or stock exchange shall be in effect; |
| -30- |
| (g) | the issue and sale of the Purchased Securities shall be exempt from the prospectus requirements of Securities Laws; and |
| (h) | the Investor shall have obtained all necessary Chinese regulatory approvals in respect of the subject matter under this Agreement and the remittance of Subscription Proceeds out of China, including, among others, approval and/or filing by/with the provincial Development and Reform Commission, the Ministry of Commerce or its local counterpart and approval by the State Administration of Foreign Exchange or its local counterpart (the “Chinese Approvals”). |
| 5.4 | Waiver of Condition |
The Company, in the case of a condition set out in Section 5.2, and the Investor, in the case of a condition set out in Section 5.3, will have the exclusive right to waive before the Closing Time, the performance or compliance of such condition in whole or in part and on such terms as may be agreed upon without prejudice to any of its rights in the event of non-performance of or non-compliance with any other condition in whole or in part. Any such waiver will not constitute a waiver of any other conditions in favour of the waiving party. Such waiving party will retain the right to complete the transactions contemplated hereby and xxx the other party in respect of any breach of the other party’s covenants or obligations or any inaccuracy or misrepresentation in a representation or warranty of the other party which gave rise to the non-performance of or non-compliance with the condition so waived.
Article 6
TERMINATION
| 6.1 | Termination Rights |
| (a) | This Agreement may be terminated at any time prior to the Closing Time by the Investor, upon written notice from the Investor to the Company, if there has been a breach of any representation, warranty or covenant on the part of the Company contained in this Agreement such that any condition specified in Section 5.3 would be incapable of being satisfied at Closing and such breach is not waived by the Investor or cured by the Company by the earlier of five Business Days after written notice thereof from the Investor and the Outside Date. |
| (b) | This Agreement may be terminated at any time prior to the Closing Time by the Company, upon written notice from the Company to the Investor, if there has been a breach of any representation, warranty or covenant on the part of the Investor contained in this Agreement such that any condition specified in Section 5.2 would be incapable of being satisfied at Closing and such breach is not waived by the Company or cured by the Investor, by the earlier of five Business Days after written notice thereof from the Company and the Outside Date. |
| (c) | This Agreement may be terminated by either the Investor or the Company, upon written notice from the party seeking to terminate this Agreement to the other party, if the Closing Date has not occurred by the Outside Date (provided that a party may not terminate this Agreement under this Section 6.1(c) if its failure to fulfill any of its obligations has been the cause of, or resulted in, the failure of Closing to occur by such date). |
| -31- |
| 6.2 | Effect of Termination |
If this Agreement is terminated pursuant to Section 6.1, all obligations of the parties under or pursuant to this Agreement will terminate without further liability of any party to the other, except that Article 7 shall survive any such termination. Notwithstanding the foregoing, termination of this Agreement pursuant to Section 6.1 shall not relieve any party from liability for any breach of this Agreement occurring before its termination.
Article 7
GENERAL PROVISIONS
| 7.1 | Notices |
| (a) | Unless otherwise specifically provided in this Agreement, any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered by hand to an officer or other responsible employee of the addressee or transmitted by facsimile transmission or other electronic communication, addressed to: |
| (i) | in the case of the Investor: | |
| Fuzhou Bonded Zone Hejili Equity Investment Limited Partnership | ||
| Attention: Xxxx Xxxxx | ||
| Facsimile: 011-86-0591-28709222 | ||
| Email: xxxxx_xxxxx@xxxxxxx.xxx | ||
| with a copy to (which shall not constitute notice): | ||
| Xxxxxxx Xxxxx LLP | ||
| 000 Xxxx Xxxxxx Xxxx, Xxxxx 0000 | ||
| Box 000, Xxx Xxxxx Xxxxxxxx Xxxxx | ||
| Xxxxxxx, Xxxxxxx, X0X 0X0 | ||
| Attention: Xxxx Xxx | ||
| Facsimile: 000-000-0000 | ||
| Email: xxxx@xxxxxxxxxxxx.xxx |
| (ii) | in the case of the Company: | |
| Hydrogenics Corporation 000 Xxxxxxx Xxxxxxxxx Xxxxxxxxxxx, Xxxxxxx X0X 0X0 |
| -32- |
| Attention: Xxx Xxxx, Chief
Financial Officer Facsimile: (000) 000-0000 Email: xxxxx@xxxxxxxxxxx.xxx | ||
| with a copy to (which shall not constitute notice): | ||
| Torys LLP 00 Xxxxxxxxxx Xxxxxx West, 30th Floor Box 270, TD Xxxxx Xxxxx Xxxxxxx, Xxxxxxx X0X 0X0 | ||
| Attention: Xxxx Xxxxxxxxxxx Facsimile: (000) 000-0000 Email: xxxxxxxxxxxx@xxxxx.xxx |
or at such other address, facsimile number or email address as such party from time to time directs in writing to the other party.
| (b) | Any notice or other communication given in accordance with this Section 7.1, if delivered by hand as aforesaid shall be deemed to have been validly and effectively given on the date of such delivery if such date is a Business Day and such delivery is received before 4:00 p.m. at the place of delivery; otherwise, it shall be deemed to be validly and effectively given on the Business Day next following the date of delivery. Any notice of communication which is transmitted by facsimile transmission or electronic mail as aforesaid, shall be deemed to have been validly and effectively given on the date of transmission if such date is a Business Day and such transmission was received before 4:00 p.m. at the place of receipt; otherwise it shall be deemed to have been validly and effectively given on the next Business Day following such date of transmission. |
| 7.2 | Indirect Actions |
A breach of this Agreement by any Investor Group Party or any Affiliate of the Investor shall be deemed a breach of this Agreement by the Investor.
| 7.3 | Public Releases |
The Company and the Investor shall consult with each other prior to issuing any press release or other public disclosure with respect to this Agreement, and the parties shall not issue such press release or make any public disclosure without the prior approval of the Company (in the case of a press release or public disclosure by the Investor) and the Investor (in the case of a press release or public disclosure by the Company), such approval not to be unreasonably withheld. Notwithstanding the foregoing, if at any time a party is required by Applicable Law to make a press release or other public disclosure (including the filing on SEDAR or XXXXX of any material change report or copy of this Agreement), such party may do so, notwithstanding the failure of the other party to approve the text of such press release or other public disclosure, provided that such party has made reasonable efforts in the particular circumstances to allow the other party a reasonable opportunity to comment on such press release or other public disclosure (including with respect to redactions to be made to this Agreement).
| -33- |
| 7.4 | Governing Law |
This Agreement shall be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein, without reference to conflicts of law rules.
| 7.5 | Arbitration |
All disputes arising out of or in connection with this Agreement shall be finally settled under the Rules of Arbitration (the “Rules”) of the International Chamber of Commerce (“ICC”), which Rules are deemed to be incorporated by reference into this clause. The tribunal shall consist of three (3) arbitrators. The Investor and the Company shall each designate one arbitrator. The third arbitrator shall be designated by the two arbitrators designated by the parties. If either the Investor or the Company fails to designate an arbitrator within thirty (30) days after the filing of a dispute with the ICC, such arbitrator shall be appointed in the manner prescribed by the Rules. Any arbitration proceeding conducted pursuant to this Agreement shall take place in Toronto, Canada, being the legal seat of the arbitration, and shall be conducted in English and Chinese. The decision or award of the arbitrators shall be in writing and shall be final and binding on the parties.
| 7.6 | Further Assurances |
Each party shall execute all such further instruments and documents and shall take all such further actions as may be necessary to effect the transactions contemplated herein, in each case at the cost and expense of the party requesting such further instrument, document or action, unless expressly indicated otherwise.
| 7.7 | Severability |
If any provision of this Agreement is wholly or partially invalid, illegal or unenforceable, this Agreement shall be interpreted as if such provision had not been a part hereof so that the invalidity, illegality or unenforceability shall not affect the validity, legality or unenforceability of the remainder of this Agreement which shall be construed as if this Agreement had been executed without such provision. Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the transactions contemplated this Agreement are fulfilled to the extent possible.
| 7.8 | Entire Agreement |
This Agreement constitutes the entire agreement among the parties pertaining to the subject matter hereof and supersedes all prior agreements, negotiations, discussions and understandings, written or oral, among the parties.
| -34- |
| 7.9 | Amendments |
This Agreement may not be changed, amended or modified in any manner, except pursuant to an instrument in writing signed on behalf of each of the parties.
| 7.10 | Waivers |
The failure by any party to enforce at any time any of the provisions of this Agreement shall in no way be construed to be a waiver of any such provision unless such waiver is acknowledged in writing, nor shall such failure affect the validity of this Agreement or any part thereof or the right of a party to enforce each and every provision. No waiver of a breach of this Agreement shall be held to be a waiver of any other or subsequent breach.
| 7.11 | Assignment |
No party may assign any of its rights or benefits under this Agreement, or delegate any of its duties or obligations, except with the prior written consent of the other parties.
| 7.12 | Successors and Assigns |
This Agreement shall enure to the benefit of and shall be binding on and enforceable by and against the parties and their respective permitted assigns and successors or executors or administrators.
| 7.13 | Third Party Beneficiaries |
Except as expressly provided otherwise herein, this Agreement is intended for the benefit of the parties and their respective successors and permitted assigns and is not for the benefit of, nor may any provision in this Agreement be enforced by, any other person.
| 7.14 | Fees and Expenses |
Each party will pay for its own costs and expenses incurred in connection with the negotiation, preparation, execution and performance of this Agreement and the transactions contemplated herein, including the fees and expenses of legal counsel, financial advisors, accountants, consultants and other professional advisors.
| 7.15 | Counterparts |
This Agreement may be executed in one or more counterparts and by the parties in separate counterparts, each of which when executed shall be deemed to be an original, but all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier or electronic format shall be effective as delivery of a manually executed counterpart of this Agreement.
[Remainder of page left intentionally blank.]
IN WITNESS WHEREOF this Agreement has been executed by the parties.
| HYDROGENICS CORPORATION | ||
| By: | “Xxxxx X.X. Xxxxxx” | |
| Name: Xxxxx X.X. Xxxxxx Title: President & Chief Executive Officer | ||
| Fuzhou Bonded Zone Hejili Equity Investment Limited Partnership (seal) | ||
| By: | XUEQING INDUSTRY INVESTMENT MANAGEMENT (PINGTAN) CO., LTD. | |
| Its: General Partner | ||
| “Xxxxxx Xxxxx” | ||
| Name: Xxxxxx Xxxxx Title: Legal Representative | ||
SCHEDULE A
COMPETITORS
[REDACTED – COMMERCIALLY SENSITIVE INFORMATION]
Exhibit A
Canadian Provincial Securities Regulatory Authorities
|
Alberta Securities Commission Xxxxx 000, 000 – 0xx Xxxxxx XX Xxxxxxx, Xxxxxxx X0X 0X0 Telephone: (000) 000-0000 Toll free in Canada: 0-000-000-0000 Facsimile: (000) 000-0000
British Columbia Securities Commission X.X. Xxx 00000, Xxxxxxx Xxxxxx 000 Xxxx Xxxxxxx Xxxxxx Xxxxxxxxx, Xxxxxxx Xxxxxxxx X0X 0X0 Inquiries: (000) 000-0000 Toll free in Canada: 1-800-373-6393 Facsimile: (000) 000-0000 Email: xxxxxxxxx@xxxx.xx.xx
The Manitoba Securities Commission 500 – 000 Xx. Xxxx Xxxxxx Xxxxxxxx, Xxxxxxxx X0X 0X0 Telephone: (000) 000-0000 Toll free in Manitoba 0-000-000-0000 Facsimile: (000) 000-0000
Financial and Consumer Services Commission (New Brunswick) 00 Xxxxxxxxx Xxxxxx, Xxxxx 000 Xxxxx Xxxx, Xxx Xxxxxxxxx X0X 0X0 Telephone: (000) 000-0000 Toll free in Canada: 1-866-933-2222 Facsimile: (000) 000-0000 Email: xxxx@xxxx.xx
Government of Newfoundland and Labrador Financial Services Regulation Division X.X. Xxx 0000 Xxxxxxxxxxxxx Xxxxxxxx 0xx Xxxxx, Xxxx Xxxxx Xxxxxx Xxxxxx Drive St. John’s, Newfoundland and Labrador A1B 4J6 Attention: Director of Securities Telephone: (000) 000-0000 Facsimile: (000) 000-0000
|
Nova Scotia Securities Commission Xxxxx 000, 0000 Xxxx Xxxxxx Xxxx Tower X.X. Xxx 000 Xxxxxxx, Xxxx Xxxxxx X0X 0X0 Telephone: (000) 000-0000 Facsimile: (000) 000-0000
Ontario Securities Commission 00 Xxxxx Xxxxxx Xxxx, 00xx Xxxxx Xxxxxxx, Xxxxxxx X0X 0X0 Telephone: (416) 000- 0000 Toll free in Canada: 1-877-785-1555 Facsimile: (000) 000-0000 Email: xxxxxxxxxxxxxxxxxxx@xxx.xxx.xx.xx Public official contact regarding indirect collection of information: Inquiries Officer
Xxxxxx Xxxxxx Island Securities Office 00 Xxxxxxxx Xxxxxx, 0xx Xxxxx Xxxx Building P.O. Box 2000 Charlottetown, Xxxxxx Xxxxxx Island C1A 7N8 Telephone: (000) 000-0000 Facsimile: (000) 000-0000
Xxxxxxxx xxx xxxxxxx xxxxxxxxxx 000, Xxxxxx Xxxxxxxx, 00x étage C.P. 000, Xxxx xx xx Xxxxxx Xxxxxxxx, Xxxxxx X0X 0X0 Telephone: (000) 000-0000 or 1-877-525-0337 Facsimile: (000) 000-0000 (For filing purposes only) Facsimile: (000) 000-0000 (For privacy requests only) Email: xxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxx.xx.xx
Financial and Consumer Affairs Authority of Saskatchewan Suite 601 - 0000 Xxxxxxxxxxxx Xxxxx Xxxxxx, Xxxxxxxxxxxx X0X 0X0 Telephone: (000) 000-0000 Facsimile: (000) 000-0000
|
